Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,326 recruiting studies in this area right now.
By phase
- Not applicable4,387
- Phase 2611
- Phase 1413
- Phase 3322
- Phase 4268
- Phase 1/Phase 2255
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer340
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer191
- Acute Kidney Injury136
- Endometriosis135
- Chronic Kidney Diseases131
- Pregnancy131
- Breast Cancer106
- Chronic Kidney Disease105
- Infertility95
- Renal Cell Carcinoma80
- Colorectal Cancer76
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Urinary Incontinence64
- Lung Cancer62
Leading sponsors
- Mayo Clinic58
- Assistance Publique - Hôpitaux de Paris47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)40
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- AstraZeneca36
- University of Aarhus36
Where studies are running
- California345
- Alabama156
- Texas121
- Massachusetts119
- New York118
- Arizona102
- Florida101
- Colorado90
- Maryland90
- Illinois79
Recruiting studies6,326 total
- NCT07217171RecruitingPhase 1
Study of EVOLVE104 for advanced bladder and squamous cell cancers
This trial tests an experimental drug called EVOLVE104 for people with advanced bladder cancer or certain types of squamous cell cancers. It aims to see if the drug is safe and if it can help shrink tumors.
Duarte, CaliforniaAges 18 years+ - NCT07399730Recruiting
Study of ravulizumab outcomes in Polish aHUS patients
This study looks at how well patients with aHUS in Poland are doing after treatment with ravulizumab (Ultomiris). It is for people who have already received this drug through the national program and agree to share their health information.
GdanskAges 18 years+ - NCT07767773Recruiting
Long-term safety of two kidney stone scope methods
This study is checking the long-term safety of two different ways of doing a kidney stone scope procedure (one uses a small tube to guide the scope, the other does not). If you had this procedure for a kidney stone (up to 20 mm) and it's been at least a year, they want to follow up with you to see how you're doing.
CairoAges 18 years+ - NCT07703917Recruiting
TENS for Uterine Pain During Breastfeeding
This study tests if a gentle electrical device (TENS) can help reduce uterine pain women sometimes feel during breastfeeding after giving birth. The results could offer a drug-free way to manage this discomfort.
NazarethAges 18 years+ - NCT07620574Enrolling by invitationPhase 3
Long-Term Study Continuing Cancer Treatment from Previous Trial
This study lets people who were in an earlier Exelixis cancer treatment trial continue receiving the same treatment if it's still helping them. It's designed to see how safe and effective the treatment is over a longer period.
Bay Shore, New YorkAges Any age - NCT06799065RecruitingPhase 1
Testing a new drug for advanced solid tumors
This trial tests ATX-295, a daily pill that blocks a protein called KIF18A, in people with advanced solid tumors, including ovarian cancer. It is for those whose cancer has grown after standard treatments or who cannot have standard therapy.
Aurora, ColoradoAges 18 years+ - NCT06966024RecruitingPhase 1
Study of DCC-2812 for advanced genitourinary cancers
This trial tests an experimental pill called DCC-2812 for people with advanced kidney, bladder, or prostate cancer. The goal is to see if it is safe and if it might help shrink tumors or slow the cancer's growth.
Boston, MassachusettsAges 18 years+ - NCT06770582RecruitingPhase 2
Adding immunotherapy to radiation for bladder cancer
This trial tests whether adding the immunotherapy drug pembrolizumab to radiation therapy works as well as or better than the usual chemotherapy given with radiation for a type of bladder cancer that has not invaded the muscle. It is for people whose cancer came back or has high-risk features and who would otherwise need to have their bladder removed.
Fayetteville, ArkansasAges 18 years+ - NCT07763613Recruiting
Study of pelvic floor strength after kidney stone surgery
This study measures a new score called the pelvic floor fatigue index, which looks at how tired the pelvic floor muscles get, in people who have a ureteral stent placed after kidney stone surgery. The goal is to see if this score can help predict or prevent bladder problems that stents can cause.
Trabzon, TrabzonAges 18–65 - NCT07182149RecruitingPhase 1
Testing a new drug for advanced solid tumors
This trial tests a new drug called NRM-823 for people with several types of advanced cancer that have stopped responding to standard treatments. The goal is to see if the drug is safe and how well it works.
Denver, ColoradoAges 18 years+ - NCT07740577RecruitingPhase 4
Preventing nausea in emergency C-section patients
This study tests two common anti-nausea drugs for women having emergency C-sections under spinal anesthesia who haven't fasted. It aims to find the best way to prevent vomiting and nausea during surgery.
Sanliurfa, EyyübiyeAges 18 years+ - NCT07768865Recruiting
Artery stiffness in young people with kidney disease
This study looks at how stiff the arteries are in children and young adults with chronic kidney disease (CKD) compared to healthy controls. The results may help doctors better understand heart risks and improve care for young people with kidney problems.
London, Greater LondonAges 10–25 - NCT07448597RecruitingPhase 4
Progesterone for preventing preeclampsia
This trial tests if taking progesterone early in pregnancy can help prevent preeclampsia, a condition of high blood pressure. You may qualify if you are over 18, speak English, and are less than 12 weeks pregnant.
Charleston, South CarolinaAges 18 years+ - NCT06998641Recruiting
Chitosan gauze for bleeding tears after childbirth
This trial tests whether a special gauze made with chitosan (a natural substance that helps blood clot) can stop bleeding from minor tears after childbirth without needing stitches. It may offer a simpler, gentler option for women with small tears.
IstanbulAges 18–48 - NCT05519241RecruitingPhase 1
Experimental bladder cancer treatment for early-stage, BCG-unresponsive disease
This phase 1 trial tests a new treatment for early-stage bladder cancer that has not responded to BCG therapy. The treatment is given directly into the bladder (intravesical), which may help avoid removing the bladder.
Boston, MassachusettsAges 18 years+ - NCT07421700RecruitingPhase 1/Phase 2
Study of PF-08634404 alone or with enfortumab vedotin for bladder cancer
This trial tests a new drug, PF-08634404, either by itself or together with another drug called enfortumab vedotin, for people with advanced bladder cancer that has spread. The goal is to see if these treatments can shrink tumors or slow the cancer's growth.
Fayetteville, ArkansasAges 18 years+ - NCT05463796Recruiting
Prevention and early detection for people at high cancer risk
This study looks at surveillance (watching closely), prevention, and early “interception” steps to lower the chance that cancer will develop or be found later. It is for people with genetic risk, past cancer treatment exposures, strong family history, or certain early pre-cancer or high-risk conditions.
Boston, MassachusettsAges Any age - NCT04723654Recruiting
Wearable sensors to monitor vital signs in kids
This trial tests wearable smart sensors that continuously track vital signs in children in the hospital (especially the ICU). It may help doctors watch changes sooner and learn how well the sensors work on children during care.
Chicago, IllinoisAges Up to 18 years - NCT07308977Recruiting
Study of assisted vaginal birth practices in Egypt
This study looks at how doctors in Egypt perform assisted vaginal deliveries. It may help understand current practices and improve training and outcomes.
CairoAges 28–60 - NCT06858319RecruitingPhase 3
Long-term study of zigakibart for IgA nephropathy
This study is for people with IgA nephropathy who completed a previous zigakibart study. It tests whether continuing treatment with zigakibart (given as a shot every two weeks) is safe and helpful over a longer period.
Denver, ColoradoAges 18–100 - NCT07440290RecruitingPhase 2/Phase 3
Dabrafenib and trametinib for BRAF V600 cancers
This trial tests two targeted drugs (dabrafenib and trametinib) for patients whose cancer has a specific change in the BRAF gene called V600. These drugs work together to block signals that help the cancer grow. The trial is for children, teenagers, and adults with many types of cancer, except for a few common ones that already have approved treatments.
BelfastAges 1 year+ - NCT07665515RecruitingPhase 1
Testing a cancer vaccine in maintenance for advanced ovarian cancer
This trial tests a vaccine called CryptiVax-1001 for people with advanced ovarian cancer who have finished first-line chemotherapy and are in remission, as maintenance therapy. The goal is to see if the vaccine can help keep the cancer from coming back.
CambridgeAges 18 years+ - NCT03626844Recruiting
Manual placenta removal after birth study
This study looks at how removing the placenta by hand after a normal vaginal birth may affect the mother. It may help doctors better manage this common procedure.
NazarethAges 18–45 - NCT07570862RecruitingPhase 2
CAR T-Cell Therapy for Hard-to-Treat Lupus Kidney Disease
This trial tests FT819, a new type of immune cell therapy (CAR T cells), for people with lupus nephritis—kidney inflammation caused by lupus—who haven't responded well to standard treatments. The goal is to see if this therapy can reduce kidney damage and improve kidney function.
Beverly Hills, CaliforniaAges 12–70
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,326 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,202 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.